Grifols, S.A. (NASDAQ:GRFS) Q1 2025 Earnings Call Transcript
Danny Segarra: Hello, everyone. My name is Danny Segarra, and myself as the Head of Investor Relations and Sustained and Vice President, Grifols.
Posts Tagged ‘NASDAQ:GRFS’
Here’s White Falcon’s Views on Grifols, S.A. (GRFS)
White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools...
Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript
Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.
Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Call Transcript
Nuria Pascual: Hello, everyone, and welcome to the Grifols Third Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.
Grifols, S.A. (NASDAQ:GRFS) Q2 2023 Earnings Call Transcript
Nuria Pascual: Hello everyone, and welcome to the Grifols' Second Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.
10 Best Pharma Stocks To Buy Now
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.
10 Best Low Price Pharma Stocks To Buy Now
The global pharmaceuticals market was forecasted to grow from $1454.66 billion in 2021 to $1587.05 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.
10 Best Medical Stocks Under $10
In this article, we will discuss the 10 best medical stocks under $10.
Is GRFS A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Is Grifols SA (GRFS) Going to Burn These Hedge Funds?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Grifols SA (GRFS) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Never Loved Grifols SA (GRFS) More
In this article we will take a look at whether hedge funds think Grifols SA (NASDAQ:GRFS) is a good investment right now.
Hedge Funds Were Dumping Grifols SA (GRFS) Before The Coronavirus
We hate to say this but, we told you so.
Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS)
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS)
We can judge whether Grifols SA (NASDAQ:GRFS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Is Grifols SA (GRFS) A Good Stock To Buy ?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Should You Buy Grifols SA (GRFS)?
"October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87...
Do Hedge Funds Love Grifols SA (GRFS)?
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Is Grifols SA, Barcelona (GRFS) A Good Stock To Buy?
It was a rough third quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during the quarter.
Billionaire John Paulson Standing Pat With His Top Small-Cap Picks
At Insider Monkey we have been touting the advantages of investing in the top small-cap picks of prominent hedge funds since our inception.
Haemonetics Corporation (HAE), Pall Corporation (PLL), Grifols SA, Barcelona (GRFS): One Blood Management Company for Red-Hot Returns
Revenue for the global blood processing products and consumables market is expected to grow at a compound annual growth rate of 8.9% over the next six years, reaching a market...
Baxter International Inc. (BAX): One Pharma Stock Investors Should Watch
Baxter International Inc. (NYSE:BAX), one of the fastest-growing healthcare multinational corporations of America, has a long history of strong financial credentials.
KAMADA ORD ILS1.00 (KMDA): Can This Small Pharma Company’s Investors Breathe Easy?
Investors have reasons to be wary about small-cap biotech companies, particularly those ambitious start-ups which have been sprouting like mushrooms in the market this year.
